Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1 participants
OBSERVATIONAL
2012-06-30
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will provide some epidemiology dates of CRC to the local Government, and assist the governor to built a more effective screening system of CRC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Diagnosis and Recurrence Monitoring of Colorectal Cancer
NCT06991452
Colorectal Cancer Screening in Chinese Rural Communities
NCT07180303
Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant Neoplasm
NCT01657773
Colorectal Cancer Screening in Xinxiang City
NCT06785714
the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT04074538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Residents in high risk group need to have some special tests, including FOBT and colonoscopy. Intestinal neoplasm will be suggested to biopsy or remove under colonoscopy for pathological examination. All tests are free. The interviews will be performed in Residential area and special tests will be done in the hospital during a regularly scheduled visit to Pu-Ai hospita.You may be contacted at home by phone so that researchers can collect information about any changes in your health status.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Resident of Qiaokou Areo,and at least ten years living history in this district
3. Willing and able to provide written informed consent and authorization
4. Willing to a personal interview and have some special tests
Exclusion Criteria
2. History of colorectal cancer
3. Mental disorders
40 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wuhan University
OTHER
Hubei Cancer Hospital
OTHER
Huazhong University of Science and Technology
OTHER
Wuhan Iron and Steel Workers' Hospital
OTHER
Wuhan Pu-Ai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Li, doctor
Role: STUDY_DIRECTOR
Zhongnan hospital of Wuhan university, China
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R201206DCAPC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.